EUVIMEDEUVIMED entdecken
Crossref

Ensuring radiotherapy excellence in SCCHN: a comprehensive cost-effectiveness analysis of holiday treatment compensation versus salvage pathways

Gustavo Pozo Rodríguez, Rafael D’ambrosi Centeno, Eduardo Cabello Murillo, Raúl Díaz Fuentes, Pedro Adaimi Hernández, Ana Isabel Milanés Gaillet, Marta Manzano Rodríguez, Ángel Gaitán Simón, María Ángeles Pérez Escutia

Reports of Practical Oncology and Radiotherapy · 16.11.2026

DOI: 10.5603/rpor.114994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 16.11.2026. Verfasst von Gustavo Pozo Rodríguez und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment interruptions in squamous cell carcinoma of the head and neck (SCCHN) significantly impair tumor control probability (TCP) due to accelerated repopulation. While compensation strategies are recommended, their implementation is often hindered by perceived economic constraints. To validate the economic sustainability of holiday compensation programs by comparing the cost of avoiding one recurrence against the financial burden of managing salvage pathways. Materials and methods: We utilized a time-driven activity-based costing (TDABC) model to map 11 clinical pathways for SCCHN. Each pathway integrates the total economic burden of a patient’s salvage trajectory, including initial diagnostic staging, specific therapeutic interventions (surgery, reirradiation, or systemic therapy), and comprehensive psycho-oncological and functional support. The economic efficiency of the holiday program was determined by calculating the investment required per recurrence prevented [program cost per patient multiplied by the number needed to treat (NNT)], subjected to a multi-factorial sensitivity analysis on recurrence risk (12–20%) and resource intensity (k = 1 to 4).

Results

The holiday compensation program demonstrates economic viability when compared to salvage management. Even under adverse scenarios — high resource intensity and low recurrence risk — the investment required to prevent one recurrence through treatment continuity remains competitive against the costs of established salvage trajectories.

Conclusions

Holiday compensation for SCCHN is not a discretionary expense but an objective economic necessity for maintaining treatment integrity. This approach provides a robust, replicable methodology for centers to transition from reactive salvage management to proactive, quality-assured radiotherapy, optimizing clinical outcomes and long-term public health sustainability.

Zitieren

APA

Rodríguez, G. P., Centeno, R. D., Murillo, E. C., Fuentes, R. D., Hernández, P. A., Gaillet, A. I. M., Rodríguez, M. M., Simón, Á. G., & Escutia, M. Á. P. (2026). Ensuring radiotherapy excellence in SCCHN: a comprehensive cost-effectiveness analysis of holiday treatment compensation versus salvage pathways. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.114994

Vancouver

Rodríguez GP, Centeno RD, Murillo EC, Fuentes RD, Hernández PA, Gaillet AIM, et al. Ensuring radiotherapy excellence in SCCHN: a comprehensive cost-effectiveness analysis of holiday treatment compensation versus salvage pathways. Reports of Practical Oncology and Radiotherapy. 2026. doi:10.5603/rpor.114994

BibTeX
@article{Rodrguez2026,
  author = {Rodríguez, Gustavo Pozo and Centeno, Rafael D’ambrosi and Murillo, Eduardo Cabello and Fuentes, Raúl Díaz and Hernández, Pedro Adaimi and Gaillet, Ana Isabel Milanés and Rodríguez, Marta Manzano and Simón, Ángel Gaitán and Escutia, María Ángeles Pérez},
  title = {Ensuring radiotherapy excellence in SCCHN: a comprehensive cost-effectiveness analysis of holiday treatment compensation versus salvage pathways},
  journal = {Reports of Practical Oncology and Radiotherapy},
  year = {2026},
  doi = {10.5603/rpor.114994}
}
Kostenlos starten →